OneSource gains EIR with VAI classification from USFDA for its BLD Facility
The report follows an inspection of the facility, conducted from November 14 to November 22, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
VAI
Lupin’s Somerset manufacturing plant receives EIR from US FDA
FDA changes inspection classification of Somerset facility to Voluntary Action Indicated (VAI)
Lupin’s Goa manufacturing plant gets EIR from US FDA
FDA changes inspection classification of the facility to Voluntary Action Indicated (VAI)
Biocon receives EIR for its Bommansandra facility
The inspection was carried out from January 20-24, 2020
Dr Reddy’s gets EIR from USFDA for Srikakulam plant
All facilities under warning letter are now determined as ‘voluntary action indicated’
Alembic Pharma gets VAI classification from USFDA for Panelav facility
The US FDA inspection was conducted from March 9-13, 2020
US FDA upgrades Jubilant’s Spokane facility to VAI status
It is indicative of the cGMP status at the facility since receiving the warning letter in 2013